Evomove - Physical therapy electrical stimulation system, battery-powered - ARTG 441931
Access comprehensive regulatory information for Evomove - Physical therapy electrical stimulation system, battery-powered in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is registered under ARTG number 441931 and sponsored by Massons Healthcare, manufactured by Evomotion GmbH in Germany. The device registration started on February 21, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
Functional Electrical Stimulation (FES) evomove - The Inertial sensor (IMU) integrated in the evomove measures the angular velocity and linear acceleration of the system. Both are used to detect walking movements. Adaptive algorithms recognize stimulation-relevant gait phases, which can be controlled by the patients. At the matching times during gait phase, the evomove triggers an electrical stimulation that improves the gait pattern. The regular use of the evomove trains muscles, regulates the tome (spasticity), reduces the formation of contractures and improves the blood circulation in the leg through the recurring contractions of the muscles. Indirectly, users train with the evomove natural gait sequences set by evomotion partner, which can support rehabilitation process.